Literature DB >> 7543349

CD5 antigen expression in B cell chronic lymphocytic leukaemia.

D Brohée1, P Cauchie, P Nève.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7543349     DOI： 10.1007/bf02999863

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  7 in total

1.  IL-10 production by CD5 B cells.

Authors:  A O'Garra; M Howard
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

2.  A further characterization of B-CLL lymphocytes: phenotypic and functional studies.

Authors:  H Merle-Béral
Journal:  Nouv Rev Fr Hematol       Date:  1990

Review 3.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

Review 4.  Chronic lymphocytic leukemia: new insights into biology and therapy.

Authors:  K A Foon; K R Rai; R P Gale
Journal:  Ann Intern Med       Date:  1990-10-01       Impact factor: 25.391

5.  Changing pattern of CD5+ CD20+ double positive lymphocytes with ageing and cytotoxic chemotherapy.

Authors:  D Brohee; M Vanhaeverbeek; B Kennes; P Neve
Journal:  Mech Ageing Dev       Date:  1991-05       Impact factor: 5.432

6.  Normal cellular counterparts of B cell chronic lymphocytic leukemia.

Authors:  A S Freedman; A W Boyd; F R Bieber; J Daley; K Rosen; J C Horowitz; D N Levy; L M Nadler
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

7.  The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.

Authors:  J V Melo; D Catovsky; D A Galton
Journal:  Br J Haematol       Date:  1986-06       Impact factor: 6.998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.